Taisho’s Prescription Drug Sales Suffer Double-Digit Decline in H1, due to Capital Tie-Up Dissolution with Toyama Chemical

October 31, 2019
Taisho Pharmaceutical Holdings’ prescription drug sales dropped to 34.7 billion yen in the April-September 2019 period, down by 12.6% year on year, due mainly to the capital alliance dissolution with Toyama Chemical, whose sales are no longer factored into the...read more